Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 4 days ago“The main behavior we should ingrain in our culture is, if you’re sick, stay home,” says Smith. “The...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 7 days agoOne of the most common reasons for bypassing the COVID vaccine is concern about side effects like tiredness, muscle and joint pain, chills, headache, fever ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 days agoPfizer’s Duchenne Therapy Study Fails: Pfizer’s phase III study, CIFFREO, evaluating its...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily ...
No Detriment to RA Starting MTX a Month After PCV13
Medscape· 8 hours agoPneumococcal vaccination administered 1 month prior to starting methotrexate (MTX) in patients with rheumatoid arthritis (RA) allows a significantly...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 7 days agoParticipants in the younger group got either the new vaccine or Spikevax and a standard-dose flu...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 7 days agoModerna said on Monday that its experimental combination vaccines against COVID-19 and the flu...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 7 days ago"Combination vaccines have the potential to reduce the burden of respiratory viruses on health...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 7 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...